# Chemistry Cost per Reportable Result (CPRR), Equipment and Reagents Canonical: https://abierto.us/opportunities/ht940825qe009 - Solicitation number: HT940825QE009 - Notice type: Special notice - Status: Closed. Deadline was September 12, 2025 at 11:00 AM EDT - Department: Department of Defense - Agency: Defense Health Agency (Dha) - Contracting office: Defense Health Agency (HT9408) - NAICS: 325413 In-Vitro Diagnostic Substance Manufacturing - Product or service code: 6550 In Vitro Diagnostic Substances, Reagents, Test Kits and Sets - Place of performance: Biloxi, Mississippi - County: Harrison County (FIPS 28047). https://abierto.us/counties/harrison-county-ms-28047 - City: Biloxi. https://abierto.us/cities/biloxi-ms-2806220 - First posted: September 10, 2025 - Last posted: September 10, 2025 - SAM.gov: https://sam.gov/workspace/contract/opp/2801e1f3afed4480b7cedcf78850937b/view ## Description The Healthcare Contracting Division – South (HCD-S), San Antonio, Texas, intends to award a firm-fixed-price (FFP) sole source contract to Siemens Healthcare Diagnostics of Tarrytown, New York to conduct Chemistry and Special Chemistry testing for Keesler Medical Center, Keesler Air Force Base, Mississippi. As a Cost-per-Reportable-Result (CPRR) vehicle, the contractor also provides all equipment, consumables, and services necessary to perform the required testing. The contract will be awarded under the authority of Federal Acquisition Regulation (FAR) 13.501. The applicable NAICS code for this requirement is 325413, In-Vitro Diagnostics Substance Manufacturing. The Small Business Size Standard is 1,250 employees. Siemens Healthcare Diagnostics is an "other-than-small business." The contract will be awarded on or before 1 October 2025. NOTE: This contract will be issued for a delivery period of 1 October 2025 -31 March 2026, with two (2) two-month option periods through 31 July 2026. This notice is not a request for competitive quotes. All responsible sources may submit a capability statement, which shall be considered by the agency before the intended award date to determine if any other entity is capable of performing the required testing. Interested sources who submit data are responsible for appropriately marking information if it is proprietary in nature. In order for the Government to consider another source, the capability statement must demonstrate the source's ability to 1) provide the required testing; 2) deliver, install, and validate the analyzer(s) to ensure patient-ready testing by 01 October 2025; and 3) ability to connect to the Defense Health Agency/Military Health System network. The Government shall not reimburse interested sources for any information provided. No requests for capability briefings will be honored as a result of this notice and any information provided will not be used as part of any subsequent solicitation requirement. No telephonic inquires will be honored. A determination by the Government not to compete with this proposed contract based upon responses to this notice is solely within the discretion of the Government. **NOTE:** INTERESTED VENDORS MUST RESPOND TO THIS NOTICE TO THE BELOW POCs ON OR BEFORE 12 SEPTEMBER 2025 BY 10 AM CENTRAL TIME IN ORDER TO BE CONSIDERED. ## Publications - September 10, 2025: Special notice, due September 12, 2025 at 11:00 AM EDT. Notice 2801e1f3afed4480b7cedcf78850937b. https://sam.gov/workspace/contract/opp/2801e1f3afed4480b7cedcf78850937b/view ## Points of contact - David Erpelding, david.k.erpelding.civ@health.mil - Carolynn Benn, carolynn.j.benn.civ@health.mil, 2108684971 --- Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/ht940825qe009.